Your browser doesn't support javascript.
loading
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study.
Song, Yuqin; Zhou, Keshu; Zou, Dehui; Zhou, Jianfeng; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Guo, Haiyi; Zhou, Lei; Huang, Jane; Novotny, William; Kim, Pil; Yu, Yiling; Wu, Binghao; Zhu, Jun.
Afiliação
  • Song Y; Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China.
  • Zhou K; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Zou D; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College, Wuhan, China.
  • Hu J; Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Yang H; Department of Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Zhang H; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Ji J; Department of Hematology, West China Hospital of Sichuan University, Chengdu, China.
  • Xu W; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Jin J; Department of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
  • Lv F; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Feng R; Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China.
  • Gao S; Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Guo H; BeiGene (Shanghai) Co., Ltd., Shanghai, China.
  • Zhou L; BeiGene (Beijing) Co., Ltd., Beijing, China; and.
  • Huang J; BeiGene USA, Inc., San Mateo, CA.
  • Novotny W; BeiGene USA, Inc., San Mateo, CA.
  • Kim P; BeiGene USA, Inc., San Mateo, CA.
  • Yu Y; BeiGene (Shanghai) Co., Ltd., Shanghai, China.
  • Wu B; BeiGene (Shanghai) Co., Ltd., Shanghai, China.
  • Zhu J; Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China.
Blood ; 139(21): 3148-3158, 2022 05 26.
Article em En | MEDLINE | ID: mdl-35303070
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma de Célula do Manto / Neutropenia Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma de Célula do Manto / Neutropenia Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China